Michelle Nnaji

The Royal Wolverhampton NHS Trust

Papers

1

Total Citations

4

H-Index

1

About

Dr. Michelle Nnaji is a rising surgical oncologist whose research is reshaping the landscape of colorectal cancer treatment, with a particular focus on minimally invasive surgical techniques. Her most-cited work, a 2024 systematic review and meta-analysis, provides a critical comparison of robotic versus transanal total mesorectal excision (TME) in rectal cancer patients, evaluating peri-operative, oncological, and functional outcomes. This study, already garnering 4 citations, underscores her commitment to evidence-based surgery and patient-centered outcomes. Dr. Nnaji’s contributions lie in advancing the understanding of how robotic-assisted approaches can improve recovery and preserve quality of life without compromising cancer control. Her work is notable for its rigorous methodology and its potential to guide clinical decision-making in a rapidly evolving field. As a researcher, she bridges the gap between technological innovation and practical surgical application, making her a key voice in the next generation of colorectal cancer specialists. Her growing citation count reflects the immediate relevance of her findings to surgeons and patients alike.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Peri-operative, oncological and functional outcomes of robotic versus transanal total mesorectal excision in patients with rectal cancer: A systematic review and meta-analysis
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: The Royal Wolverhampton NHS Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago